Objectives: Helicobacter pylori is the major cause of peptic ulcers and gastric cancer in humans. Treatment involves a drug cocktail, typically including amoxicillin. Increasing levels of resistance to amoxicillin contribute to treatment failures. Higher levels of resistance are believed to be due to multiple genetic mutations, likely due to higher fitness cost of resistance mutations in a single gene. The progression of β -lactam resistance mutations in multiple genes and the effects of those mutations at various intervals has not been investigated. In this study we examined the evolution of amoxicillin resistance in H. pylori when exposed to increasing concentrations of amoxicillin in -vitro.
Introduction
Colonization of the stomach by Helicobacter pylori is often asymptomatic; however, this colonization can trigger an inflammatory response responsible for a majority of cases of peptic ulcers, stomach cancers and B-cell mucosa-associated lymphoid tissue (MALT) lymphomas. 1, 2 Two or more antibiotics are generally used to treat persistent and symptomatic infections of H. pylori but ultimately may not be effective due to increasing rates of antibiotic resistance. 3 H. pylori has been shown to possess a high mutation rate 4 with specific point mutations in the bacterial genome resulting in increasing levels of resistance to various antibiotics 5 , including the ®β-lactams 6 . Moreover, recent studies have shown that unsuccessful eradication of H. pylori after treatment with amoxicillin leads to an increase of amoxicillin resistance in these bacteria. 7 
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Previous studies have demonstrated that certain point mutations in penicillin-binding protein-1 (PBP1) confer resistance to β-lactam antibiotics in H. pylori. [8] [9] [10] [11] [12] However, these studies, as well as others demonstrate that PBP1 point mutations can only account for low levels of amoxicillin resistance, suggesting that high levels of resistance must require additional resistance mechanisms. 13, 14 In this study we track the emergence of a high level amoxicillin resistant strain of H. pylori in vitroin vitro. Using whole genome sequencing and comparison to the parental amoxicillin sensitive strain, we identified changes that occurred within the bacterial chromosome affecting amoxicillin susceptibility. By sequencing strains with intermediate levels of amoxicillin resistance which emerged on the path to the highly resistant strain, we established the sequence in which these mutations originated. Our results provide evidence for the complexity of the evolution of amoxicillin resistance in H. pylori, and identify a variety of genes which can contribute to this resistance.
Materials and Methods

Bacterial strains and culture conditions
H. pylori ATCC strain 26695 was used as the amoxicillin-sensitive reference strain and the parental strain to create the in vitroin vitro resistant isolates. All bacterial strains were incubated at 37°C in a humidified 10% CO 2 
General DNA techniques
All DNA manipulations were performed according to standard protocols. Primers used in this study were created using the published sequence of genes from 26695 and Vector NTI (Invitrogen, Carlsbad, CA) and synthesized by Sigma-Aldrich (The Woodlands, TX).
Polymerase chain reaction (PCR) was performed in an automated thermal cycler PTC100 (MJ Research, Ramsey, MN), using the Choice-Taq Blue TM DNA polymerase (Denville Scientific, Metuchen, NJ). PCR products were run on 1% agarose gels (Biorad, Hercules, CA) and subsequently cut and purified using the Minelute agarose purification system (Qiagen Inc., Valencia, CA). Sequencing of purified DNA products was performed by the Genomics Core facility at the University of California, Riverside. Sequence analysis and alignments were performed using Vector NTI.
Isolation of amoxicillin resistant strains
Strain 26695, an amoxicillin sensitive strain with a fully sequenced genome 15 , was used as the starting culture to create amoxicillin resistant isolates. Serial two-fold dilutions of amoxicillin were prepared in Brucella broth supplemented with 10% heat-inactivated fetal bovine serum and 1% IsoVitalex in a 96 well plate. Wells contained sequentially- isolates labeled IS1-IS5. MICs to amoxicillin of all isolates were determined using the broth microdilution method according to a previously published protocol. 16 
MIC values
were also determined in 0.5 mg/L increments for amoxicillin concentrations between 1 and 8 mg/L.
Whole genome sequencing
An Illumina genomic DNA sample prep kit (Illumina, Inc., San Diego, CA) was used to create the genomic library. All subsequent reactions were performed according to instructions. Five µg of genomic DNA from the final isolate was sheared by sonication to obtain fragments of about 400bp. The ends were repaired by converting overhangs from fragmentation into blunt ends, using T4 DNA polymerase and E. coli DNA polymerase I Klenow. Further, an A base was added to the 3' end of the blunt phosphorylated DNA fragments using the polymerase activity of Klenow. Specific DNA adapters were ligated to the ends of the DNA fragments, to prepare them to be hybridized to a flow cell. The ligation product was purified using a PCR purification kit (Promega).
This purified product was submitted to the Genome center at UCR where it was sequenced with the Illumina Genome Analyzer using single read at 32bp per read.
The data were then put through the flowcell pipeline in the form of short reads. These short reads were assembled and analyzed for Single Nucleotide Polymorphisms (SNPs) and single base pair Insertions or Deletions (InDels) by the Bioinformatics department at UCR. The alignment put forth was also visually inspected to locate any changes missed by data mining.
Identifying potential targets and their evolution
SNPs and single insertions and deletions were analyzed for mutations resulting in amino acid changes within genes. Mutations in the last 6 amino acids of a protein or not within a coding or promoter region were excluded. Potential target genes were sequenced in the parental strain 26695 to identify mutations present prior to the in vitroin vitro amoxicillin resistant isolation process. PCR primers were created for each of the potential targets and synthesized by Sigma Genosys. The potential target genes were then PCR amplified from the genomic DNA of each isolate and sequenced as mentioned above. The sequencing data were analyzed to confirm the presence or absence of the target mutations in each isolate. Cells were scraped from the plate and re-suspended in sterile PBS followed by plating on Brucella-sheep blood agar containing either 0.125µg/ml or 0.25µg/ml amoxicillin.
Transformation of Helicobacter pylori
Individual colonies were isolated and targeted genes were sequenced to verify mutation. penicillin G to a final concentration of 1µCi/ml at 37ºC to both halves. Half ml aliquots were removed at 1, 5, 10 and 30 min. The cells were then washed and analyzed as mentioned above.
Efflux pump inhibitor assay
Using the microdilution MIC method mentioned above, susceptibility of 26695, IS3, IS4
and IS5 to amoxicillin was studied in the presence or absence of NMP (Naphthylmethyl- Initial studies focused on the IS5 isolate. To determine the sequence changes conferring resistance to IS5, potential target genes such as PBPs 1-3, Hop A-E, and Mre ABC genes were sequenced and compared to those in the parental strain 26695. However, only three of these genes, pbp1, pbp2 and hopC, from IS5 showed amino acid changes when compared to 26695 (see Table 1 ). The sequence of PBP1 (HP0597) from IS5 showed two amino acid changes: P372S and T438M. Upon sequencing the pbp1 genes in the 5
isolates, IS1-IS5, the P372S substitution appeared in IS1 whereas the T438M mutation appeared first in IS4 (Table 1) . Sequence comparisons of PBP2 in each of the 5 isolates (IS1-IS5) and parental strain 26695 revealed the E536K mutation only in IS5 (Table 1) .
Sequence comparisons of Hop C in each isolate and 26695 revealed a single mutation resulting in the conversion of an arginine to a histidine, R302H (Table 1) , which appeared first in IS2 (Table 1) .
Judging by the level of total resistance, and the presence of 5 isolates with distinct MICs, it seemed plausible that there were other changes which had not yet been detected. were not present before selection of resistant isolates. Fifteen of these mutations were present in the amoxicillin sensitive parental strain eliminating them as potential resistance targets.
It can be challenging to look for InDels of unspecified lengths. So in order to cover the entire genome and acquire any information that data mining may have missed, we scrolled through the alignment of genome with its short basepair reads using samstools on the biocluster server at University of California, Riverside. The alignment file showed a high quality of the short reads and the alignment. Scrolling through the alignment helped to identify four deletions of about 20-30 bps. These were also present in the parental strain 26695 and were not further analyzed.
A total of nine genes and eleven mutations emerged as potential resistance targets including PBP1, PBP2 and HopC. The loci of these changes, the precise amino acid change(s) that occurred, and the function of these genes are shown in Table 1 . Two genes contain two mutations each, namely PBP1 and acriflavin resistance protein (AcrB).
Further sequencing of these mutations in IS1-IS5 showed the order in which they evolved (Table 1) . IS1 contains the P372S mutation in PBP1 as well as a mutation in HP0181
which is a putative colicin V protein. Of the eleven mutations, four mutations, AcrB, Hop C, Hypothetical Na+/H+ antiporter and Flagellin A, appeared first in IS2. IS3 has an additional mutation in AcrB and a mutation in the promoter region of DNA glycosylase.
IS4 contains the T438M mutation in PBP1, while IS5 contains mutations in PBP2 and
HofH, a putative outer membrane protein. 
C] penicillin G accumulation
In order to determine whether amoxicillin resistance could be attributed to changes in antibiotic access to its periplasmic target, we performed radiolabelled penicillin G accumulation experiments. We had determined in previous studies 16, 17 that penicillin G could be used as a surrogate β-lactam drug for amoxicillin because it had similar binding affinities for PBP1. As shown in Figure 2 , at each time point examined, isolates IS3 and IS5 accumulated less penicillin than the parental amoxicillin sensitive strain 26695. Over Finally, we examined the effect of efflux pump inhibitors (EFIs) on amoxicillin susceptibility was examined using isolated strains s and the broth microdilution MIC method described previously. To increase sensitivity in this assay, 0.5 mg/L increments were used between 1-8 mg/L amoxicillin. Initially, theThe MICs of amoxicillin for strains 26695, IS3, IS4 and IS5 were determined when incubated in the presence or absence of either 100 mg/L of NMP or PAβN. As shown in Table 2 , the MIC for strain 26695 was unaffected by the presence or absence of EFIs. In contrast, isolate IS3, which contains two mutations in AcrB, was more sensitive to amoxicillin when grown in either EFI, reducing the MIC by 1.0 mg/L (from 2.5 to 1.5). Similarly, isolates IS4 and IS5
were also slightly more amoxicillin sensitive in the presence of an EFI, with an MIC change of 1.0 mg/L for both IS4 (3.5 to 2.5) and IS5 (4.0 to 3.0).
Transformation and mutagenesis of 26695
Based on the studies with isolated strains IS1 -IS5, we were particularly interested in assessing the effect of individual proteins with mutations on amoxicillin sensitivity, particularly PBP1, PBP2, HopC, HofH and AcrB. We have previously reported that PBP1 andshown that HopC mutations affect amoxicillin sensitivity 13, 18 .
. , In this study, wWwe were able toe created individual transformants containing the mutated PBP1, HofH and AcrB mutations found in IS5, but were unable to select a PBP2 mutant transformant. As shown in Table 3 , These individual transformant strains containing mutated PBP1, HofH or AcrBs each increased amoxicillin resistance 4x over that of the parental strain 26695. In additionAlthough, the presence of the efflux pump inhibitoreither EFI , NMP , or PAβN, did not have a significant impact on the resistance provided by either PBP1 or HofH, . However, a dramatic reversion to the 26695 levels of susceptibility was noticed for AcrB mutants when grown in the presence of either EFINMP.
Discussion
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The goals of this study were to characterize the evolution of amino acid changes in H.
pylori genes when exposed to increasing levels of amoxicillin in vitroin vitro, and to identify the mechanisms of resistance contributed by these mutated genes. As described in the results section we successfully isolated 5 amoxicillin resistant strains, with progressively increasing resistance levels and identified a total of 11 amino acid changes within 9 genes which we believe account for the majority of the observed amoxicillin resistance. In addition, using individual mutants, this study has demonstrated the significance of specific mutations within PBP1, HofH and AcrB that impact amoxicillin susceptibility.
IS1 has an MIC value of 0.5 mg/L and contains two mutations. One mutation is P372S in HP0597 (PBP1) which is located adjacent to the penicillin binding module (PBM)
sequence SAIK which contains the putative catalytic Ser 368 in the middle of the putative catalytic site. A point mutation is found in HP0946, a conserved membrane protein and a homolog of Nhac; Na+/H+ antiporter; anion permease. A direct connection has not been made between this protein and β-lactam resistance; however differences in expression levels of similar ion transport proteins have been seen when exposed to amoxicillin. 19 The point mutation seen in HP0958, a posttranscriptional regulator for Flagellin A (FlaA) protein, seems like 13 an unlikely target to confer resistance to β-lactams; however a study has shown that two genes involved in production of flagella are differentially expressed when the cells are exposed to amoxicillin. 19 The third isolate IS3 shows an MIC value of 2.5 mg/L and possesses two additional changes from above. HP0602, a 3 methyl DNA glycosylase, possesses a single base pair change in its promoter region. There is no evidence that this gene plays any role in conferring resistance to β-lactams. The L378F amino acid substitution is the second change in AcrB protein.
The penicillin accumulation assays showed that IS3 and IS5 had a marked decrease in the amount of antibiotic present within the cell when compared to the parental strain 26695.
Accumulation assays however do not distinguish between decrease in uptake, binding or presence of an efflux mechanism. Initial attempts to identify efflux mechanisms using the proton motive force inhibitor CCCP in IS5 were unsuccessful as H. pylori did not grow in CCCP, but similar results were seen in other bacteria with efflux mechanisms. 25 This led us to investigate alternative methods to detect the influence of an active efflux pump. Bacterial starvation experiments showed a decrease in penicillin accumulation upon end of starvation suggesting the possible contribution of activation of efflux pumps. This is consistent with the understanding that H. pylori would have difficulty maintaining a proton motive force when incubated in PBS. 26 More directly, the MICs of IS3, IS4 and IS5 were decreased when exposed to either of 2 efflux pump inhibitors (EFIs), again indicating that part of the amoxicillin resistance shown might be related to an efflux mechanism. Hirata et al. 27 reported that the MIC for clarithromycin was decreased in H. pylori in the presence of PAβN, the same EFI used in this study. Since the effects of these EFIs decreased the MIC by 1.0 mg/L in IS3, and the same amounts in IS4 and IS5, we would suggest that the presence of the 2 AcrB mutations in these 3 isolates is responsible for this level of amoxicillin resistance.
Previous studies have shown that a single V-F mutation in AcrB protein of E. coli increases its resistance to several antibiotics. 28 The crystal structure of AcrB protein in E.
14 coli shows a symmetric trimer of the transporter. Recent studies by Trainor et al. 24 demonstrated that the HefC efflux pump in H. pylori provides some resistance to bile salts and ceragenins.
Collectively, this study and previous studies point to a role for active efflux pumps in H.
pylori resistance to various compounds, including antibiotics.
IS4 contains a single additional mutation T438M in PBP1, which has been previously characterized and shown to have a 4 fold increase in resistance to β-lactams. This mutation has been shown to map within the putative binding cleft of PBP1 of H. pylori. 
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The region around the E536K mutation seems to be conserved in some related bacteria (data not shown), suggesting functional importance of this site within PBP2. The role of PBPs other than PBP1 in conferring resistance to β-lactams has been previously shown in several other bacteria. 30 A G228W mutation is found in HP1167 which is a putative outer membrane protein known as Omp3 or HofH. This point mutation occurs at a highly conserved glycine residue and would likely affectimpact protein structure and potentially function. The presence of this mutation transformed into strain 26695 increases amoxicillin resistance 4x. This might explain the decreased penicillin accumulation seen in IS5 relative to IS3 (Figure 2 ) -however further studies are needed to document this role for Omp3.
In conclusion, we hypothesize that the majority of high level amoxicillin resistance in pylori would allow the development of better methods for its control and detection. replicate experiments using a paired t-test.
Funding
This study was supported by funding from the Division of Biomedical Sciences, University of California, Riverside.
Transparency
None to declare.
